Elevated platelet β-secretase activity in mild cognitive impairment

Dementia and Geriatric Cognitive Disorders

Volumn 24, Issue 6, 2007, Pages 464-468

  Liu, W W ^a   Todd, S ^a   Craig, D ^a   Passmore, A P ^a   Coulson, D T R ^a   Murphy, S ^a   Irvine, G B ^a   Johnston, J A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Amyloid precursor protein; Biomarker; Neurodegeneration; Platelet secretase activity

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BIOLOGICAL MARKER;

AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLUOROMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE MEMBRANE;

AGED; AMYLOID PRECURSOR PROTEIN SECRETASES; BLOOD PLATELETS; BRAIN; COGNITION DISORDERS; FEMALE; HUMANS; MALE; NERVE DEGENERATION; NEUROPSYCHOLOGICAL TESTS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 36448969439     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110739     Document Type: Article

References (18)

1. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B; International Psychogeriatric Association Expert Conference on mild cognitive impairment: Mild cognitive impairment. Lancet 2006;367:1262-1270.
2. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC: Mild cognitive impairment - Beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J Intern Med 2004;256:240-246.
3. Small GW, Kepe V, Barrio JR: Seeing is believing: neuroimaging adds to our understanding of cerebral pathology. Curr Opin Psychiatry 2006;19:564-569.
4. Frank RA, Galasko D, Hampel H, Hardy J, de Leon MJ, Mehta PD, Rogers J, Siemers E, Trojanowski JQ; National Institute on Aging Biological Markers Working Group: Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol Aging 2003;24:521-536.
5. Johnston JA, Cowburn RF, Norgren S, Wiehager B, Venizelos N, Winblad B, Vigopelfrey C, Schenk D, Lannfelt L, Oneill C: Increased beta-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease App670/671 mutation. FEBS Lett 1994;354:274-278.
6. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S: Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996;2:864-870.
7. Fukumoto H, Cheung BS, Hyman BT, Irizarry MC: Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 2002;59:1381-1389.
8. Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G: Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Ann Neurol 2002;51:783-786.
9. Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, Beach T, Sue L, Sabbagh M, Cai H, Wong P, Price D, Shen Y: Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proc Natl Acad Sci USA 2004;101:3632-3637.
10. Holsinger RM, McLean CA, Collins SJ, Masters CL, Evin G: Increased beta-secretase activity in cerebrospinal fluid of Alzheimer's disease subjects. Ann Neurol 2004;55:898-899.
11. Johnston JA, Liu WW, Coulson DT, Todd S, Murphy S, Brennan S, Foy CJ, Craig D, Irvine GB, Passmore AP: Platelet beta-secretase activity is increased in Alzheimer's disease. Neurobiol Aging 2006, DOI: 10.1016/j.neurobiolaging. 2006.11.003.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
13. Vassar R: The beta-secretase, BACE: a prime drug target for Alzheimer's disease. J Mol Neurosci 2001;17:157-170.
14. Rosenberg RN, Baskin F, Fosmire JA, Risser R, Adams P, Svetlik D, Honig LS, Cullum CM, Weiner MF: Altered amyloid protein processing in platelets of patients with Alzheimer disease. Arch Neurol 1997;54:139-144.
15. Di Luca M, Pastorino L, Bianchetti A, Perez J, Vignolo LA, Lenzi GL, Trabucchi M, Cattabeni F, Padovani A: Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Arch Neurol 1998;55:1195-1200.
16. Baskin F, Rosenberg RN, Iyer L, Hynan L, Cullum CM: Platelet APP isoform ratios correlate with declining cognition in AD. Neurology 2000;54:1907-1909.
17. Padovani A, Borroni B, Colciaghi F, Pettenati C, Cottini E, Agosti C, Lenzi GL, Caltagirone C, Trabucchi M, Cattabeni F, Di Luca M: Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch Neurol 2002;59:71-75.
18. Colciaghi F, Marcello E, Borroni B, Zimmermann M, Caltagirone C, Cattabeni F, Padovani A, Di Luca M: Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease. Neurology 2004;62:498-501.